Which pharma companies spent the most in print journals in 2014?

In 2014, Johnson & Johnson spent more than $34 million advertising its drug products in professional health journals, meaning it comprises 6% of the total market share among all companies. 2014 was Johnson & Johnson's second year in a row as the top spender. Both AstraZeneca and GlaxoSmithKline are new to the top three.

Top 5 Print Ad Pharmaceutical Companies (Dollars): January–December 2014
  1. Johnson & Johnson – $34 MM (-17%)
  2. AstraZeneca – $19 MM (+65%)
  3. GlaxoSmithKline – $15 MM (+27%)
  4. Pfizer – $13 MM (+.3%)
  5. Novartis – $11 MM (+6%)

The percentage changes in parentheses compare 2014 to 2013. For more information on these ad insights or other data, contact us.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in professional healthcare.




Search article